The prognostic value of lymph node status among breast cancer subtypes

American Journal of Surgery

Volumn 209, Issue 4, 2015, Pages 717-724

  Liao, Guo Shiou ^a   Chou, Yu Ching ^b   Hsu, Huan Ming ^a   Dai, Ming Shen ^a   Yu, Jyh Cherng ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Breast cancer subtypes; Lymph node status; Overall survival; Recurrence free survival

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; SEX HORMONE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TUMOR VOLUME; BREAST TUMOR; CLASSIFICATION; DISEASE FREE SURVIVAL; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84925257429     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2014.05.029     Document Type: Article

References (34)

1. C.M. Perou, T. Sørlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
2. A. Goldhirsch, W.C. Wood, and A.S. Coates Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
3. M. Puig-Vives, M.J. Sanchez, and J. Sanchez-Cantalejo Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study Gynecol Oncol 130 2013 609 614
4. A. Crispo, M. Barba, and G. D'Aiuto Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series BMC cancer 13 2013 15
5. F.M. Blows, K.E. Driver, and M.K. Schmidt Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies PLoS Med 7 2010 e1000279
6. P. Minicozzi, F. Bella, and A. Toss Relative and disease-free survival for breast cancer in relation to subtype: a population-based study J Cancer Res Clin Oncol 139 2013 1569 1577
7. C. Mazouni, F. Rimareix, and M.C. Mathieu Outcome in breast molecular subtypes according to nodal status and surgical procedures Am J Surg 205 2013 662 667
8. N.K. Howland, T.D. Driver, and M.P. Sedrak Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer J Surg Res 185 2013 697 703
9. B. Fisher, M. Bauer, and D.L. Wickerham Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer 52 1983 1551 1557
10. P.J. Dings, M.A. Elferink, and L.J. Strobbe The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study Ann Surg Oncol 20 2013 2607 2614
11. S.G. Wu, Z.Y. He, and Q. Li Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients PloS One 8 2013 e61410
12. P.R. Rosen, S. Groshen, and P.E. Saigo A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma J Clin Oncol 7 1989 355 366
13. B. Salhia, C. Tapia, and E.A. Ishak Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology BMC Womens Health 11 2011 44
14. G. Singh Ranger, and K. Mokbel The evolving role of sentinel lymph node biopsy for breast cancer Eur J Surg Oncol 29 2003 423 425
15. F. Reyal, R. Rouzier, and B. Depont-Hazelzet The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma PLoS One 6 2011 e20297
16. T. Jones, H. Neboori, and H. Wu Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer? Ann Surg Oncol 20 2013 2866 2872
17. Y. Akasbi, S. Bennis, and F. Abbass Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez) BMC Res Notes 4 2011 500
18. R.W. Carlson, and S.B. Edge Update: NCCN breast cancer clinical practice guidelines J Natl Compr Cancer Netw 2 Suppl. 3 2004 S-1 S-4
19. C. Xue, X. Wang, and R. Peng Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China Cancer Sci 103 2012 1679 1687
20. S.T. Chen, H.W. Lai, and H.S. Tseng Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women Jpn J Clin Oncol 41 2011 1327 1335
21. N.D. Arvold, A.G. Taghian, and A. Niemierko Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy J Clin Oncol 29 2011 3885 3891
22. J.A. van der Hage, J.S. Mieog, and C.J. van de Velde Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials Breast Cancer Res 13 2011 R68
23. L. Schwentner, A. Wöckel, and J. König Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients BMC Cancer 13 2013 487
24. J. Li, A.M. Gonzalez-Angulo, and P.K. Allen Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer Oncologist 16 2011 1675 1683
25. N.L. Ferguson, J. Bell, and R. Heidel Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women Breast J 19 2013 22 30
26. S.J. Crabb, M.C. Cheang, and S. Leung Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer Clin Breast Cancer 8 2008 249 256
27. B. Van Calster, I. Vanden Bempt, and M. Drijkoningen Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive Breast Cancer Res Treat 113 2009 181 187
28. O. Brouckaert, S. Pintens, and V. Van Belle Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors Breast Cancer Res Treat 115 2009 349 358
29. R. Bhargava, J. Striebel, and S. Beriwal Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers Int J Clin Exp Pathol 2 2009 444 455
30. C.K. Anders, A.M. Deal, and C.R. Miller The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases Cancer 117 2011 1602 1611
31. S. Zheng, Q.K. Song, and Y. Ren The characteristics of breast cancer subtypes: implications for treatment guidelines and individualized treatment strategies in China Appl Immunohistochem Mol Morphol 22 2014 383 389
32. Z.S. Li, L. Yao, and Y.Q. Liu Breast cancer subtypes and survival in Chinese women with operable primary breast cancer Chin J Cancer Res 23 2011 134 139
33. A. Garcia Fernandez, C. Chabrera, and M. Garcia Font Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012 Tumour Biol 34 2013 2349 2355
34. A.K. Falck, P.O. Bendahl, and G. Chebil Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up Breast Cancer Res Treat 140 2013 93 104